T1	Chemical 10 19	Tamoxifen
T3	Gene_or_protein 51 57	CYP2D6
T4	Phenotype 184 212	recurrences of breast cancer
T5	Disease 199 212	breast cancer
T6	Haplotype 51 69	CYP2D6 alleles * 4
T7	Haplotype 51 65;72 75	CYP2D6 alleles * 5
T8	Haplotype 51 65;78 82	CYP2D6 alleles * 10
T9	Haplotype 51 65;85 89	CYP2D6 alleles * 41
T10	Phenotype 223 243	relapse-free periods
T2	Phenotype 322 347	event-free survival rates
T11	Pharmacodynamic_phenotype 111 159	impaired formation of antiestrogenic metabolites
R1	increases Arg1:T9 Arg2:T4	
R2	increases Arg1:T8 Arg2:T4	
R3	increases Arg1:T7 Arg2:T4	
R4	increases Arg1:T6 Arg2:T4	
R5	decreases Arg1:T6 Arg2:T10	
R6	decreases Arg1:T9 Arg2:T10	
R7	decreases Arg1:T8 Arg2:T10	
R8	decreases Arg1:T7 Arg2:T10	
R9	decreases Arg1:T6 Arg2:T2	
R10	decreases Arg1:T8 Arg2:T2	
R11	decreases Arg1:T9 Arg2:T2	
R12	decreases Arg1:T7 Arg2:T2	
R13	isAssociatedWith Arg1:T6 Arg2:T11	
R14	isAssociatedWith Arg1:T9 Arg2:T11	
R15	isAssociatedWith Arg1:T8 Arg2:T11	
R16	isAssociatedWith Arg1:T7 Arg2:T11	
